Reply to: "Reply to: 'Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries'". (2018)

First Author: Da Silva Filipe A

Attributed to: Viral Hepatitis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jhep.2017.11.044

PubMed Identifier: 29339112

Publication URI: http://europepmc.org/abstract/MED/29339112

Type: Journal Article/Review

Volume: 68

Parent Publication: Journal of hepatology

Issue: 4

ISSN: 0168-8278